Decision Aid for Thyroid Cancer

YH
Overseen ByYinin Hu, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Maryland, Baltimore
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

Low-risk thyroid cancer grows very slowly. More than 99% of patients with this cancer survive for at least 5 years. There are 3 main treatment options: remove the whole thyroid, remove just the part of the thyroid with the cancer in it, or leave the cancer in the thyroid and monitor it. Survival is similar across the 3 main treatment options. It can be difficult for patients to choose a treatment option, especially when feeling anxious about the cancer diagnosis. In this study, enrolled patients will receive a decision aid after finding out they have cancer but before meeting a surgeon. This decision aid is a pamphlet. It gives information about the treatment options and a list of questions for patients to ask their surgeons at their clinic visit. The investigators will test whether this aid changes patient decision anxiety and decision readiness.

Are You a Good Fit for This Trial?

Inclusion Criteria

English-speaking
I have low-risk thyroid cancer or a thyroid nodule that may be cancerous.

Exclusion Criteria

I have talked to a surgeon about my thyroid nodule or cancer.
I have had thyroid cancer in the past.
I have had thyroid surgery in the past.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Decision Aid Intervention

Participants receive a decision aid pamphlet after cancer diagnosis but before meeting a surgeon

4 weeks
1 visit (in-person)

Follow-up

Participants are monitored for decision anxiety and readiness after receiving the decision aid

2 weeks
1 visit (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • Decision Aid

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: All ParticipantsExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Maryland, Baltimore

Lead Sponsor

Trials
729
Recruited
540,000+